Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.030
+0.020 (1.98%)
At close: Mar 9, 2026, 4:00 PM EDT
1.050
+0.020 (1.94%)
After-hours: Mar 9, 2026, 7:30 PM EDT
Cocrystal Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 14 | 21 | 18 | 16 | 63 | 93 | |
| Market Cap Growth | -28.66% | 17.29% | 10.34% | -74.94% | -32.06% | 435.38% | |
| Enterprise Value | 8 | 9 | -12 | -26 | 2 | 62 | |
| Last Close Price | 1.03 | 2.02 | 1.72 | 1.95 | 7.80 | 16.32 | |
| PS Ratio | - | - | - | - | - | 46.30 | |
| PB Ratio | 1.75 | 2.16 | 0.66 | 0.40 | 0.82 | 1.78 | |
| P/TBV Ratio | 1.85 | 2.16 | 0.66 | 0.40 | 1.08 | 2.79 | |
| EV/Sales Ratio | - | - | - | - | - | 30.84 | |
| Debt / Equity Ratio | 0.21 | 0.19 | 0.07 | 0.01 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -0.80 | -0.85 | -0.93 | -0.93 | -0.75 | -0.62 | |
| Net Debt / EBITDA Ratio | 0.64 | 0.45 | 1.17 | 2.05 | 4.15 | 3.44 | |
| Net Debt / FCF Ratio | 0.64 | 0.49 | 1.66 | 1.71 | 4.56 | 3.22 | |
| Asset Turnover | - | - | - | - | - | 0.05 | |
| Quick Ratio | 5.42 | 4.56 | 8.35 | 31.14 | 38.00 | 24.72 | |
| Current Ratio | 5.78 | 4.77 | 8.92 | 33.04 | 38.40 | 25.05 | |
| Return on Equity (ROE) | -94.94% | -97.50% | -54.54% | -66.32% | -21.81% | -24.67% | |
| Return on Assets (ROA) | -45.77% | -49.98% | -36.68% | -18.86% | -13.30% | -14.48% | |
| Return on Capital Employed (ROCE) | -109.40% | -162.10% | -75.60% | -45.80% | -18.30% | -18.10% | |
| Earnings Yield | -68.12% | -85.17% | -102.64% | -244.58% | -22.39% | -10.35% | |
| FCF Yield | -67.81% | -80.25% | -84.38% | -135.46% | -20.16% | -10.80% | |
| Buyback Yield / Dilution | -1.91% | -5.42% | -18.52% | -10.58% | -60.04% | -73.32% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.